These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 15050906

  • 1. Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography.
    Borah B, Dufresne TE, Chmielewski PA, Johnson TD, Chines A, Manhart MD.
    Bone; 2004 Apr; 34(4):736-46. PubMed ID: 15050906
    [Abstract] [Full Text] [Related]

  • 2. The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover.
    Borah B, Ritman EL, Dufresne TE, Jorgensen SM, Liu S, Sacha J, Phipps RJ, Turner RT.
    Bone; 2005 Jul; 37(1):1-9. PubMed ID: 15894527
    [Abstract] [Full Text] [Related]

  • 3. Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography.
    Borah B, Dufresne TE, Ritman EL, Jorgensen SM, Liu S, Chmielewski PA, Phipps RJ, Zhou X, Sibonga JD, Turner RT.
    Bone; 2006 Aug; 39(2):345-52. PubMed ID: 16571382
    [Abstract] [Full Text] [Related]

  • 4. Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography.
    Dufresne TE, Chmielewski PA, Manhart MD, Johnson TD, Borah B.
    Calcif Tissue Int; 2003 Nov; 73(5):423-32. PubMed ID: 12964065
    [Abstract] [Full Text] [Related]

  • 5. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis.
    Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ.
    J Bone Miner Res; 2001 Jan; 16(1):97-103. PubMed ID: 11149495
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.
    Recker RR, Delmas PD, Halse J, Reid IR, Boonen S, García-Hernandez PA, Supronik J, Lewiecki EM, Ochoa L, Miller P, Hu H, Mesenbrink P, Hartl F, Gasser J, Eriksen EF.
    J Bone Miner Res; 2008 Jan; 23(1):6-16. PubMed ID: 17892374
    [Abstract] [Full Text] [Related]

  • 8. Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis.
    Ste-Marie LG, Sod E, Johnson T, Chines A.
    Calcif Tissue Int; 2004 Dec; 75(6):469-76. PubMed ID: 15478000
    [Abstract] [Full Text] [Related]

  • 9. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR, Bare SP, Smith SY, Varela A, Miller MA, Morris SA, Fox J.
    Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
    [Abstract] [Full Text] [Related]

  • 10. Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women.
    Zoehrer R, Roschger P, Paschalis EP, Hofstaetter JG, Durchschlag E, Fratzl P, Phipps R, Klaushofer K.
    J Bone Miner Res; 2006 Jul; 21(7):1106-12. PubMed ID: 16813531
    [Abstract] [Full Text] [Related]

  • 11. Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography.
    Borah B, Dufresne TE, Chmielewski PA, Gross GJ, Prenger MC, Phipps RJ.
    J Bone Miner Res; 2002 Jul; 17(7):1139-47. PubMed ID: 12096826
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body.
    Chevalier Y, Quek E, Borah B, Gross G, Stewart J, Lang T, Zysset P.
    Bone; 2010 Jan; 46(1):41-8. PubMed ID: 19800436
    [Abstract] [Full Text] [Related]

  • 14. Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate.
    Durchschlag E, Paschalis EP, Zoehrer R, Roschger P, Fratzl P, Recker R, Phipps R, Klaushofer K.
    J Bone Miner Res; 2006 Oct; 21(10):1581-90. PubMed ID: 16995813
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vertebral fractures are associated with increased cortical porosity in iliac crest bone biopsy of men with idiopathic osteoporosis.
    Ostertag A, Cohen-Solal M, Audran M, Legrand E, Marty C, Chappard D, de Vernejoul MC.
    Bone; 2009 Mar; 44(3):413-7. PubMed ID: 19071239
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Early estrogen replacement therapy reverses the rapid loss of trabecular bone volume and prevents further deterioration of connectivity in the rat.
    Lane NE, Haupt D, Kimmel DB, Modin G, Kinney JH.
    J Bone Miner Res; 1999 Feb; 14(2):206-14. PubMed ID: 9933474
    [Abstract] [Full Text] [Related]

  • 19. Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization.
    Yao W, Balooch G, Balooch M, Jiang Y, Nalla RK, Kinney J, Wronski TJ, Lane NE.
    Bone; 2006 Sep; 39(3):460-9. PubMed ID: 16713415
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.